Trial Profile
Case Series of Continuously-infused Amphotericin-B and Follow-up Voriconazole Therapy for Severe Blastomycosis Pulmonary Infections
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Amphotericin B (Primary) ; Voriconazole (Primary) ; Voriconazole (Primary)
- Indications Blastomycosis; Respiratory tract infections
- Focus Pharmacokinetics
- Acronyms BLASTO
- 25 Sep 2020 Status changed from recruiting to discontinued.
- 09 Sep 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2020.
- 09 Sep 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2020.